Literature DB >> 4803439

Inactivated influenza vaccines. 2. Laboratory indices of protection.

W R Dowdle, M T Coleman, S R Mostow, H S Kaye, S C Schoenbaum.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4803439      PMCID： PMC2495389          DOI： 10.1136/pgmj.49.569.159

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  The diagnosis of Asian influenza virus infection after recent immunization.

Authors:  G RAPMUND; R T JOHNSON; A S BANKHEAD; Y F HERMAN; O W DANDRIDGE
Journal:  U S Armed Forces Med J       Date:  1959-06

2.  Studies with avian influenza A viruses: cross protection experiments in chickens.

Authors:  W H Allan; C R Madeley; A P Kendal
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

3.  A common surface antigen in influenza viruses from human and avian sources.

Authors:  R G Webster; H G Pereira
Journal:  J Gen Virol       Date:  1968-09       Impact factor: 3.891

4.  Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation.

Authors:  J C Hierholzer; M T Suggs; E C Hall
Journal:  Appl Microbiol       Date:  1969-11

5.  Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.

Authors:  J L Schulman; M Khakpour; E D Kilbourne
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

6.  Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

7.  Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.

Authors:  S C Schoenbaum; S R Mostow; W R Dowdle; M T Coleman; H S Kaye
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

8.  A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.

Authors:  W P Edmondson; R Rothenberg; P W White; J M Gwaltney
Journal:  Am J Epidemiol       Date:  1971-06       Impact factor: 4.897
  8 in total
  26 in total

1.  High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

Authors:  E Kretzschmar; L Buonocore; M J Schnell; J K Rose
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Virology       Date:  2011-01-08       Impact factor: 3.616

3.  A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.

Authors:  Laurent Coudeville; Philippe Andre; Fabrice Bailleux; Françoise Weber; Stanley Plotkin
Journal:  Hum Vaccin       Date:  2010-10-01

4.  A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity.

Authors:  M I Brady; I G Furminger
Journal:  J Hyg (Lond)       Date:  1976-10

Review 5.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

6.  Preparation and properties of a novel influenza subunit vaccine.

Authors:  H Bachmayer; E Liehl; G Schmidt
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

Review 7.  Immunobiology of influenza vaccines.

Authors:  Margarita M Gomez Lorenzo; Matthew J Fenton
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

8.  Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis.

Authors:  R Al-Khayatt; R Jennings; C W Potter
Journal:  J Hyg (Lond)       Date:  1984-10

9.  Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.

Authors:  Laurent Coudeville; Fabrice Bailleux; Benjamin Riche; Françoise Megas; Philippe Andre; René Ecochard
Journal:  BMC Med Res Methodol       Date:  2010-03-08       Impact factor: 4.615

Review 10.  Chikungunya virus and prospects for a vaccine.

Authors:  Scott C Weaver; Jorge E Osorio; Jill A Livengood; Rubing Chen; Dan T Stinchcomb
Journal:  Expert Rev Vaccines       Date:  2012-09       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.